Chromatin mapping and single-cell immune profiling define the temporal dynamics of ibrutinib response in CLL
Ibrutinib, a Bruton tyrosine kinase inhibitor, provides effective treatment for chronic lymphocytic leukemia (CLL). Here, the authors describe time-dependent molecular changes to malignant cells and to the immune system in patients undergoing ibrutinib therapy, with can be used for therapy monitorin...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/73b869eadff94edea5bfbf6a4cfbce75 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:73b869eadff94edea5bfbf6a4cfbce75 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:73b869eadff94edea5bfbf6a4cfbce752021-12-02T17:32:59ZChromatin mapping and single-cell immune profiling define the temporal dynamics of ibrutinib response in CLL10.1038/s41467-019-14081-62041-1723https://doaj.org/article/73b869eadff94edea5bfbf6a4cfbce752020-01-01T00:00:00Zhttps://doi.org/10.1038/s41467-019-14081-6https://doaj.org/toc/2041-1723Ibrutinib, a Bruton tyrosine kinase inhibitor, provides effective treatment for chronic lymphocytic leukemia (CLL). Here, the authors describe time-dependent molecular changes to malignant cells and to the immune system in patients undergoing ibrutinib therapy, with can be used for therapy monitoring.André F. RendeiroThomas KrausgruberNikolaus FortelnyFangwen ZhaoThomas PenzMatthias FarlikLinda C. SchusterAmelie NemcSzabolcs TasnádyMarienn RétiZoltán MátraiDonát AlpárCsaba BödörChristian SchmidlChristoph BockNature PortfolioarticleScienceQENNature Communications, Vol 11, Iss 1, Pp 1-14 (2020) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Science Q |
spellingShingle |
Science Q André F. Rendeiro Thomas Krausgruber Nikolaus Fortelny Fangwen Zhao Thomas Penz Matthias Farlik Linda C. Schuster Amelie Nemc Szabolcs Tasnády Marienn Réti Zoltán Mátrai Donát Alpár Csaba Bödör Christian Schmidl Christoph Bock Chromatin mapping and single-cell immune profiling define the temporal dynamics of ibrutinib response in CLL |
description |
Ibrutinib, a Bruton tyrosine kinase inhibitor, provides effective treatment for chronic lymphocytic leukemia (CLL). Here, the authors describe time-dependent molecular changes to malignant cells and to the immune system in patients undergoing ibrutinib therapy, with can be used for therapy monitoring. |
format |
article |
author |
André F. Rendeiro Thomas Krausgruber Nikolaus Fortelny Fangwen Zhao Thomas Penz Matthias Farlik Linda C. Schuster Amelie Nemc Szabolcs Tasnády Marienn Réti Zoltán Mátrai Donát Alpár Csaba Bödör Christian Schmidl Christoph Bock |
author_facet |
André F. Rendeiro Thomas Krausgruber Nikolaus Fortelny Fangwen Zhao Thomas Penz Matthias Farlik Linda C. Schuster Amelie Nemc Szabolcs Tasnády Marienn Réti Zoltán Mátrai Donát Alpár Csaba Bödör Christian Schmidl Christoph Bock |
author_sort |
André F. Rendeiro |
title |
Chromatin mapping and single-cell immune profiling define the temporal dynamics of ibrutinib response in CLL |
title_short |
Chromatin mapping and single-cell immune profiling define the temporal dynamics of ibrutinib response in CLL |
title_full |
Chromatin mapping and single-cell immune profiling define the temporal dynamics of ibrutinib response in CLL |
title_fullStr |
Chromatin mapping and single-cell immune profiling define the temporal dynamics of ibrutinib response in CLL |
title_full_unstemmed |
Chromatin mapping and single-cell immune profiling define the temporal dynamics of ibrutinib response in CLL |
title_sort |
chromatin mapping and single-cell immune profiling define the temporal dynamics of ibrutinib response in cll |
publisher |
Nature Portfolio |
publishDate |
2020 |
url |
https://doaj.org/article/73b869eadff94edea5bfbf6a4cfbce75 |
work_keys_str_mv |
AT andrefrendeiro chromatinmappingandsinglecellimmuneprofilingdefinethetemporaldynamicsofibrutinibresponseincll AT thomaskrausgruber chromatinmappingandsinglecellimmuneprofilingdefinethetemporaldynamicsofibrutinibresponseincll AT nikolausfortelny chromatinmappingandsinglecellimmuneprofilingdefinethetemporaldynamicsofibrutinibresponseincll AT fangwenzhao chromatinmappingandsinglecellimmuneprofilingdefinethetemporaldynamicsofibrutinibresponseincll AT thomaspenz chromatinmappingandsinglecellimmuneprofilingdefinethetemporaldynamicsofibrutinibresponseincll AT matthiasfarlik chromatinmappingandsinglecellimmuneprofilingdefinethetemporaldynamicsofibrutinibresponseincll AT lindacschuster chromatinmappingandsinglecellimmuneprofilingdefinethetemporaldynamicsofibrutinibresponseincll AT amelienemc chromatinmappingandsinglecellimmuneprofilingdefinethetemporaldynamicsofibrutinibresponseincll AT szabolcstasnady chromatinmappingandsinglecellimmuneprofilingdefinethetemporaldynamicsofibrutinibresponseincll AT mariennreti chromatinmappingandsinglecellimmuneprofilingdefinethetemporaldynamicsofibrutinibresponseincll AT zoltanmatrai chromatinmappingandsinglecellimmuneprofilingdefinethetemporaldynamicsofibrutinibresponseincll AT donatalpar chromatinmappingandsinglecellimmuneprofilingdefinethetemporaldynamicsofibrutinibresponseincll AT csababodor chromatinmappingandsinglecellimmuneprofilingdefinethetemporaldynamicsofibrutinibresponseincll AT christianschmidl chromatinmappingandsinglecellimmuneprofilingdefinethetemporaldynamicsofibrutinibresponseincll AT christophbock chromatinmappingandsinglecellimmuneprofilingdefinethetemporaldynamicsofibrutinibresponseincll |
_version_ |
1718380127803408384 |